(PWRM, CLNO, SWIR, CRAY, NUAN) Hot Stock by Stock-PR.com

Seeking Alpha Analyst Since 2011
<p align="center">Stock-PR Reporting</p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com" target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg" /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835"></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085"></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup" target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg" width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong><img style="WIDTH: 176px; HEIGHT: 76px" height="63" alt="power3" hspace="0" src="pennyomega.com/img/power3.png" width="152" align="bottom" border="0" /> Power3 Medical Products, Inc. (OTC:PWRM)<br /></strong><br />
The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.<br />
<br />
The primary symptoms of Parkinson's disease are due to excessive muscle contraction. Acetylcholine stimulates muscle contraction. Dopamine reduces muscle contraction. So Parkinson's disease consequently occurs when the effect of dopamine is less than that of acetylcholine. Dopamine deficiency rather than acetylcholine excess is normally responsible for this occurring.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Power3 Medical Products, Inc</strong>. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.<br />
<br />
Please visit Power3 Medical Products, Inc website</font> <a href="www.power3medical.com"><font color="black">www.power3medical.com</font></a><font color="black">.<br />
<br />
**********************************<br />
<br />
<strong><img class="alignnone size-full wp-image-16467" title="Clean" style="WIDTH: 250px; HEIGHT: 64px" height="64" alt="clno_logo_250x64" hspace="0" src="crwefinance.com/img/clno_logo_250x64.jpg" width="250" align="bottom" border="0" /> Cleantech Transit Inc. (OTCPK:CLNO)<br /></strong><br />
<strong>Cleantech Transit Inc</strong>. recently reported the commencement of the final permitting prior to going online at Merced. The Merced project is a 500 Kilowatt biomass-generated power plant that is fully constructed, owned and operated by Phoenix Energy (</font><a href="www.phoenixenergy.net"><font color="black">phoenixenergy.net</font></a><font color="black">).<br />
The Merced project received permission for parallel testing to the grid. This testing process would allow Merced to connect to the grid on its own.<br />
<br />
Biomass includes all of the earth's living matter, plants and animals, and the remains of this living matter. It provides not only food but also energy, building materials, paper, fabrics, medicines and chemicals. Biomass has been used for energy purposes ever since man discovered fire. Today, biomass fuels can be utilized for tasks ranging from heating the house to fuelling a car and running a computer. When biomass is produced by plants as a result of photosynthesis, some of the energy in the sunlight is converted into the chemical energy that binds various atoms to form carbohydrate molecules.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Cleantech Transit Inc</strong>. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (</font><a href="www.phoenixenergy.net"><font color="black">phoenixenergy.net</font></a><font color="black">). This project can generate shareholder returns as well benefit the Company's manufacturing client's worldwide.Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.<br />
<br />
Please visit Cleantech Transit, Inc. website</font> <a href="www.cleantechtransitinc.com"><font color="black">cleantechtransitinc.com</font></a><font color="black">.<br />
<br />
*******************************************************<br />
<br />
<strong>Sierra Wireless Inc. (Nasdaq:SWIR)</strong> reported first quarter 2011 results. All results are reported in U.S. dollars and are prepared in accordance with United States generally accepted accounting principles ("GAAP"), except as otherwise indicated below. Revenue for the first quarter of 2011 was $144.3 million, a decrease of 5% compared to $151.3 million in the first quarter of 2010. Mobile Computing revenue was $71.6 million, up 14% compared to $62.6 million in the first quarter of 2010. Machine-to-Machine ("M2M") revenue was $72.7 million, down 18% compared to $88.7 million in the first quarter of 2010. The year-over-year revenue decrease in M2M was driven by significantly lower sales to Barnes & Noble, declining from $26.7 million in the first quarter of 2010 to $0.7 million in the first quarter of 2011, offset by solid year-over-year revenue growth of 16% in the remainder of the M2M business.<br />
<br />
Sierra Wireless, Inc., together with its subsidiaries, provides wireless solutions for the machine-to-machine (M2M) and mobile computing markets. Sierra Wireless, Inc. was founded in 1993 and is headquartered in Richmond, Canada.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black">************************<br />
<br />
<strong>Cray Inc. (Nasdaq:CRAY)</strong> announced financial results for the first quarter ended March 31, 2011. Revenue for the quarter was $39.9 million compared to $28.4 million in the prior year period. The company reported a net loss for the quarter of ($1.5 million) or ($0.04) per share compared to a net loss of ($11.6 million) or ($0.34) per share in the first quarter of 2010. Total gross profit margin for the first quarter 2011 was 43% compared to 23% for the first quarter of 2010. For the first quarter 2011, product margin was 32% and service margin was 51%. First quarter 2011 service margin benefited as new, large systems went into production and also benefited from revenue on a custom engineering contract on which costs were recognized in a prior period.<br />
<br />
Cray Inc. engages in the design, development, manufacture, marketing, and service of high-performance computing (HPC) systems, known as supercomputers. Cray Inc. was founded in 1987 and is headquartered Seattle, Washington.<br />
<br />
************************</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Nuance Communications, Inc. (Nasdaq:NUAN)</strong> announced financial results for its second quarter of fiscal 2011, ended March 31, 2011. Nuance reported GAAP revenue of $319.0 million in the second quarter of fiscal 2011, a 16.8% increase over GAAP revenue of $273.0 million in the second quarter of fiscal 2010. Nuance reported non-GAAP revenue of $332.0 million, which includes $13.0 million in revenue lost to accounting treatment in conjunction with acquisitions. Second quarter fiscal 2011 non-GAAP revenue grew 13.4% over non-GAAP revenue of $292.8 million in the same quarter last year. In the second quarter of fiscal 2011, Nuance recognized GAAP net income of $1.7 million, or $0.01 per diluted share, compared with GAAP net loss of ($15.4) million, or ($0.05) per share, in the second quarter of fiscal 2010. In the second quarter of fiscal 2011, Nuance reported non-GAAP net income of $99.9 million, or $0.32 per diluted share, compared to non-GAAP net income of $83.3 million, or $0.28 per diluted share, in the second quarter of fiscal 2010. Nuance's non-GAAP operating margin was 32.9% for the second quarter of fiscal 2011, compared to 32.0%, in the second quarter of fiscal 2010. Nuance reported cash flow from operations of $96.1 million in the second quarter of fiscal 2011, compared to $55.5 million in the second quarter of fiscal 2010. Nuance ended the second quarter of fiscal 2011 with a balance of cash and marketable securities of $678.6 million.<br />
<br />
Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.</font><br /></span></span></span></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40" target="_blank"><font color="red">stock-pr.com/disclaimer</font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font><font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (OTCPK:CLNO).</font></strong></span></span></p>
<p> </p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup" target="_blank">stock-pr.com/signup</a></p>
<p align="center"><a href="www.crownequityholdings.com" target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg" src="stock-pr.com/img/stock-pr_buscard.jpg" /></a></p>
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.